C-peptide improves autonomic nerve function in IDDM patients

Area of Science:

• Endocrinology
• Neurology
• Metabolic Disorders

Background:

• Diabetic polyneuropathy is a common complication of insulin-dependent diabetes mellitus (IDDM).
• C-peptide, a byproduct of insulin production, has been investigated for potential therapeutic roles in diabetes.
• Autonomic nerve dysfunction is a significant aspect of diabetic polyneuropathy.

Purpose of the Study:

• To investigate the influence of C-peptide on nerve function in patients with IDDM and symptoms of diabetic polyneuropathy.
• To assess the effects of C-peptide infusion on autonomic nerve function, sensory thresholds, and nerve conduction.

Main Methods:

• A double-blind study involving 12 IDDM patients with diabetic polyneuropathy.
• Patients underwent tests of autonomic nerve function (respiratory heart rate variability, brake index), sensory thresholds, and nerve conduction before and during a 3-hour intravenous infusion of either C-peptide or saline.
• Plasma C-peptide levels were monitored.

Main Results:

• C-peptide infusion significantly increased respiratory heart rate variability and the brake index, indicating improved autonomic nerve function.
• No significant changes were observed in clinical neurological examinations, sensory thresholds, or nerve conduction measurements.
• Saline infusion did not produce similar improvements in autonomic function tests.

Conclusions:

• Short-term (3-hour) infusion of C-peptide at physiological amounts may improve autonomic nerve function in patients with IDDM.
• C-peptide shows potential as a therapeutic agent for managing autonomic neuropathy in diabetic patients.
• Further research is warranted to explore the long-term effects and mechanisms of C-peptide in diabetic nerve complications.